PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31881647-5	2019	Blood glucose area under the curve (AUC) was significantly lower in the reheated (703 +- 56 mmol L-1 min-1) than the hot condition (735 +- 77 mmol L-1 min-1, t ( 92 ) = -3.36, pbonferroni = 0.003), with no significant difference with the cold condition (722 +- 62 mmol L-1 min-1).	Glucose	6-13	immunoglobulin kappa variable 1-16	Homo sapiens	97-106	
31881647-5	2019	Blood glucose area under the curve (AUC) was significantly lower in the reheated (703 +- 56 mmol L-1 min-1) than the hot condition (735 +- 77 mmol L-1 min-1, t ( 92 ) = -3.36, pbonferroni = 0.003), with no significant difference with the cold condition (722 +- 62 mmol L-1 min-1).	Glucose	6-13	immunoglobulin kappa variable 1-16	Homo sapiens	147-156	
31881647-5	2019	Blood glucose area under the curve (AUC) was significantly lower in the reheated (703 +- 56 mmol L-1 min-1) than the hot condition (735 +- 77 mmol L-1 min-1, t ( 92 ) = -3.36, pbonferroni = 0.003), with no significant difference with the cold condition (722 +- 62 mmol L-1 min-1).	Glucose	6-13	immunoglobulin kappa variable 1-16	Homo sapiens	147-156	
31545516-9	2019	CONCLUSION: Survival media must maintain physiological pH (>5.5) be isotonic with skin cells (300 mOsm kg-1 ) and contain at least 0.5 g L-1 glucose.	Glucose	141-148	immunoglobulin kappa variable 1-16	Homo sapiens	137-140	
30548823-3	2019	Through condition optimization, 51 mM laminaribiose is produced from 10 g L-1 maltodextrin (55.5 mM glucose equivalent) and 90 mM glucose.	Glucose	100-107	immunoglobulin kappa variable 1-16	Homo sapiens	74-77	
30941478-7	2019	Under the optimized conditions, the limits of detection achieved for glucose and nitrite were 27 mumol L-1 and 7 mumol L-1, respectively.	Glucose	69-76	immunoglobulin kappa variable 1-16	Homo sapiens	103-122	
30099155-6	2018	In contrast, we observed a modest improvement on methane production (>10% compared to the control lacking GO) using 5 mg of GO L-1 in glucose-amended incubations.	Glucose	137-144	immunoglobulin kappa variable 1-16	Homo sapiens	130-133	
30677699-3	2019	We conducted enzymatic semi-hydrolysis of paper pulp without pretreatment and with low enzyme loading, which produced high concentrations of cellobiose (13.9 g L-1) and glucose (21.3 g L-1).	Glucose	169-176	immunoglobulin kappa variable 1-16	Homo sapiens	185-188	
30620558-3	2019	The laccase enzyme was produced in high yield at pH of 5 and glucose concentration of 10 g L-1.	Glucose	61-68	immunoglobulin kappa variable 1-16	Homo sapiens	91-94	
28467384-2	2017	In batch fermentations, the bioconversion of glucose is strongly inhibited in the presence of more than 100 g L-1 lactic acid and is only possible when the product is simultaneously removed, which can be achieved by ceramic membrane filtration.	Glucose	45-52	immunoglobulin kappa variable 1-16	Homo sapiens	110-113	
29998704-2	2018	The results showed that the ANAMMOX bacteria promoted ANAMMOX-MFC denitrification when the concentration of glucose was low (100-200 mg L-1).	Glucose	108-115	immunoglobulin kappa variable 1-16	Homo sapiens	136-139	
29998704-4	2018	The electrogenesis production performance and NH4+-N removal rate gradually decreased when the glucose concentration was higher than 300 mg L-1, but the NO2--N removal rate generally remained unchanged.	Glucose	95-102	immunoglobulin kappa variable 1-16	Homo sapiens	140-143	
29636747-6	2018	A glucose concentration of 0.5 g L-1 was best for PNP degradation.	Glucose	2-9	immunoglobulin kappa variable 1-16	Homo sapiens	33-36	
29965687-4	2018	The SAD process performed well with an average total nitrogen concentration in the effluent of 6.41 mg L-1 when 30 mg L-1 glucose was added to the effluent sewage at ambient temperature.	Glucose	122-129	immunoglobulin kappa variable 1-16	Homo sapiens	103-106	
29965687-4	2018	The SAD process performed well with an average total nitrogen concentration in the effluent of 6.41 mg L-1 when 30 mg L-1 glucose was added to the effluent sewage at ambient temperature.	Glucose	122-129	immunoglobulin kappa variable 1-16	Homo sapiens	118-121	
29965687-6	2018	The stability of the SAD process was destroyed and the SAD process turned into a denitrification process when 30 mg L-1 glucose was added in the influent sewage in a low temperature environment.	Glucose	120-127	immunoglobulin kappa variable 1-16	Homo sapiens	116-119	
29414174-4	2018	High levels of glucose (228.1 g L-1) and fructose (55.7 g L-1) were efficiently produced within 12 h at a solid-to-liquid ratio of 37.5% (w/v) in 2.5 L bioreactors.	Glucose	15-22	immunoglobulin kappa variable 1-16	Homo sapiens	32-35	
29414174-4	2018	High levels of glucose (228.1 g L-1) and fructose (55.7 g L-1) were efficiently produced within 12 h at a solid-to-liquid ratio of 37.5% (w/v) in 2.5 L bioreactors.	Glucose	15-22	immunoglobulin kappa variable 1-16	Homo sapiens	58-61	
28630579-6	2017	However, the postprandial exercise bout tended to decrease the area under the glucose curve after the evening meal compared to the fasted exercise bout (24.2 +- 6.2 vs. 27.6 +- 6.0 mmol hour L-1, p = 0.031).	Glucose	78-85	immunoglobulin kappa variable 1-16	Homo sapiens	191-194	
28630579-7	2017	Furthermore, the postprandial exercise decreased the mean of the 10 highest glucose values measured in each individual (8.6 +- 1.9 mmol L-1) over 22 hours compared to both the control day (9.3 +- 2.1 mmol.L-1) and the day with fasted exercise (9.6 +- 1.7 mmol L-1, p = 0.012 and 0.009 respectively).	Glucose	76-83	immunoglobulin kappa variable 1-16	Homo sapiens	136-139	
10063642-1	1999	Helicobacter pylori NCTC 11637 produces a water-insoluble biofilm when grown under defined conditions with a high carbon:nitrogen ratio in continuous culture and in 10% strength Brucella broth supplemented with 3 g l-1 glucose.	Glucose	219-226	immunoglobulin kappa variable 1-16	Homo sapiens	215-218	
27709794-6	2017	Glucose (AUCglucose 319 +- 30 [placebo] vs 315 +- 18 mmol.L-1 .min-1 [sitagliptin], Delta 7 [95% confidence interval -50 to 63] mmol.L-1 .min-1 ), insulin, C-peptide and glucagon concentrations were not affected significantly by sitagliptin treatment ( P = .60-1.00).	Glucose	0-7	immunoglobulin kappa variable 1-16	Homo sapiens	58-61	
27709794-6	2017	Glucose (AUCglucose 319 +- 30 [placebo] vs 315 +- 18 mmol.L-1 .min-1 [sitagliptin], Delta 7 [95% confidence interval -50 to 63] mmol.L-1 .min-1 ), insulin, C-peptide and glucagon concentrations were not affected significantly by sitagliptin treatment ( P = .60-1.00).	Glucose	0-7	immunoglobulin kappa variable 1-16	Homo sapiens	133-136	
25058849-8	2014	A comparison between visits revealed that mean glycogen concentrations were significantly greater during the glucose visit (control visit, AUC = 218 +- 39 mol L(-1) min(-1); glucose visit, AUC = 305 +- 49 mol L(-1) min(-1); P < 0.05).	Glucose	109-116	immunoglobulin kappa variable 1-16	Homo sapiens	159-164	
22833369-7	2013	A proof-of-principle experiment for the one-pot bio-ester production from glucose led to 5 g L(-1) butyl butyrate in the hexadecane phase.	Glucose	74-81	immunoglobulin kappa variable 1-16	Homo sapiens	93-98	
26667831-4	2016	Glucose was completely consumed, while 61% of the xylose was consumed at the lowest dilution rate, leading to an overall solvent productivity of 0.65 g L(-1) h(-1) and a high concentration of 185 g kg(-1) solvents in the permeate in the last fermentation zone during 192 h. Based on the experimental results, a process integrated with organophilic pervaporation was conceptually designed and compared with a base-case.	Glucose	0-7	immunoglobulin kappa variable 1-16	Homo sapiens	152-157	
23911977-3	2013	Our model system consists of ubiquitin, a protein whose dynamic features are closely related to its ability to bind to multiple partners, in a 325 g L-1 solution of glucose in water, a condition widely employed in in vitro studies of crowding effects.	Glucose	165-172	immunoglobulin kappa variable 1-16	Homo sapiens	149-152	
2042020-4	1991	The Cytur-test was inhibited by glucose at 25 g l-1 and by albumin at 10 g l-1.	Glucose	32-39	immunoglobulin kappa variable 1-16	Homo sapiens	48-51	
1368115-2	1992	The aim of the study was to make the measurements under typical conditions found in alcoholic fermentations, such as the concentrations of glucose (100 g l-1) and ethanol (50 g l-1), the simultaneous counter-diffusion of glucose and ethanol, and the presence of cells in the gel beads at a level of 10(9) cells g-1 of beads.	Glucose	139-146	immunoglobulin kappa variable 1-16	Homo sapiens	154-157	
1895359-14	1991	Where substrate provision is more important, a more concentrated solution, incorporating large amounts of glucose polymers in concentrations of 150-200 g l-1, is to be preferred.	Glucose	106-113	immunoglobulin kappa variable 1-16	Homo sapiens	154-157	
2042020-5	1991	However, the median (range) concentrations of glucose and albumin of 60 dialysis effluents was 1.8 g l-1 (0.9-10.6 g l-1) and 1.1 g l-1 (0.3-5.2 g l-1) respectively.	Glucose	46-53	immunoglobulin kappa variable 1-16	Homo sapiens	101-104	
2042020-5	1991	However, the median (range) concentrations of glucose and albumin of 60 dialysis effluents was 1.8 g l-1 (0.9-10.6 g l-1) and 1.1 g l-1 (0.3-5.2 g l-1) respectively.	Glucose	46-53	immunoglobulin kappa variable 1-16	Homo sapiens	117-120	
2042020-5	1991	However, the median (range) concentrations of glucose and albumin of 60 dialysis effluents was 1.8 g l-1 (0.9-10.6 g l-1) and 1.1 g l-1 (0.3-5.2 g l-1) respectively.	Glucose	46-53	immunoglobulin kappa variable 1-16	Homo sapiens	117-120	
2042020-5	1991	However, the median (range) concentrations of glucose and albumin of 60 dialysis effluents was 1.8 g l-1 (0.9-10.6 g l-1) and 1.1 g l-1 (0.3-5.2 g l-1) respectively.	Glucose	46-53	immunoglobulin kappa variable 1-16	Homo sapiens	117-120